Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 6, 2015

View Archived Issues

New clamp assay detects mutational spectrum of a tumor in patient serum

Astellas review progress of first quarter of fiscal 2015

Lilly reports FFAR1 agonists

Sorrento Therapeutics licenses ex-Chinese rights to Mabtech Ltd biologics

GSK reviews progress of late-stage pipeline in second quarter 2015

Novartis patents SHP-2 inhibitors

University of California, Oakland, presents prodrugs of RTC-13

Sarmont discloses NO donors

Cadila Healthcare reports development of lipid lowering agents

BrightGene Bio-Medical Technology develops folate receptor ligands

Viewpoint Molecular Targeting and RadioMedix secure NCI grant for image guided therapy

Baxalta board rejects unsolicited acquisition proposal from Shire

New findings suggest therapeutic potential of Cirara to reduce edema in ischemic stroke

Antares Pharma starts phase III trial of subcutaneous testosterone in hypogonadism

FDA awards fast track designation to Marina Biotech's CEQ-508 for FAP

RVT-101 improves cognition and function as an adjunct therapy to donepezil

La Jolla Pharmaceutical enters exclusive license agreements for LJPC-30Sa and LJPC-30Sb

AstraZeneca licenses adenosine A2A receptor antagonist from Heptares Therapeutics

Endo sells men's health businesses to Boston Scientific and plans to reorganise Litha

ISIS Pharmaceuticals presents preliminary data for ISIS-TTRRx

Diurnal and National Institutes of Health's CRADA extended

Coferon describes bivalent Bcr-Abl tyrosine kinase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...